Achieve Life Sciences ACHV Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash
Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies
Other financials
Where this comes from
Reported directly by Achieve Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.
The official record: Achieve Life Sciences’s 10-K, filed March 24, 2026, on SEC EDGAR. View the filing →
Ask your AI about Achieve Life Sciences's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Achieve Life Sciences's effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?
- Achieve Life Sciences (ACHV) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $4K in Q4 2025.
- What does effect of currency exchange rate changes on cash, cash equivalents, and restricted cash mean?
- Represents the impact of fluctuations in foreign currency exchange rates on the reported value of cash, cash equivalents, and restricted cash balances. This metric helps investors isolate the effect of currency volatility from actual operational cash flows. It is essential for understanding the stability of liquid assets held in non-functional currencies.